Ferghana’s global focus on all aspects of the Life Sciences industry (drugs, devices, and diagnostics) makes the firm unusually well qualified to handle Divestment assignments (sales) on behalf of our Clients, whether these sale mandates relate to a specific molecule/asset, a major division, a technology, or the outright sale of an entire company. By working within the economic and legal context applicable to each market, Ferghana effectively represents its Client’s interests by providing the best choice of local or international company to acquire the business to be divested.
Ferghana advises its Clients as to the best selling strategy to be followed (such as full auction, controlled invitational auction, or bilateral sale negotiations). In most instances, the preferred sale route for the Client to ensure the best return is the auction sale. Ferghana has particular expertise in auction sales and has created a rigorous and tightly controlled divestment process.